2. Anti-infection Metabolic Enzyme/Protease
  3. SARS-CoV Angiotensin-converting Enzyme (ACE)
  4. Etesevimab

Etesevimab  (Synonyms: CB 6; JS016)

Cat. No.: HY-P99347 Purity: 98.76%
SDS COA

Molarity Calculator

Etesevimab (JS016) is a recombinant neutralizing human IgG1 anti-SARS-CoV-2 monoclonal antibody.

For research use only. We do not sell to patients.

CAS No. : 2423948-94-9

Size Price Stock Quantity
1 mg USD 300 In-stock
5 mg USD 780 In-stock
10 mg USD 1250 In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Etesevimab Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Etesevimab (JS016) is a recombinant neutralizing human IgG1 anti-SARS-CoV-2 monoclonal antibody[1].

Isotype

Human IgG1 kappa
Recommend Isotype Controls
Species

Human
IC50 & Target

Kd: 6.45 nM (SARS-CoV-2 spike protein)[1]
IC50: 0.32 nM (spike protein attachment to ACE2)[1]
In Vitro

Etesevimab (JS016) binds the spike protein with a Kd of 6.45 nM and blocks spike protein attachment to the human angiotensin converting enzyme 2 (ACE2) receptor with an IC50 value of 0.32 nM (0.046 μg/mL)[1].
Etesevimab blocks viral cell fusion to prevent SARS-CoV-2 invasion of human cells and inhibits viral replication[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Etesevimab Related Antibodies
Clinical Trial
CAS No.
Appearance

Liquid

Color

Colorless to light yellow

SMILES

[Etesevimab]
Shipping

Shipping with dry ice.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Format
  • Human IgG1 kappa
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Etesevimab Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Etesevimab2423948-94-9CB 6 JS016CB6CB-6JS016JS 016JS-016SARS-CoVAngiotensin-converting Enzyme (ACE)SARS coronavirusInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Etesevimab
Cat. No.:
HY-P99347
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (251 KB) Français - FR (251 KB) Deutsch - DE (251 KB) Norwegian - NO (251 KB) Español - ES (251 KB) Swedish - SV (251 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.